Q2 EPS Estimate for Gain Therapeutics Increased by Analyst
Gain Therapeutics, Inc. (NASDAQ:GANX – Free Report) – Analysts at HC Wainwright increased their Q2 2025 earnings estimates for shares of Gain Therapeutics in a note issued to investors on Monday, May 19th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings of ($0.16) per share for the quarter, up from […]
Gain Therapeutics, Inc. (NASDAQ:GANX – Free Report) – Analysts at HC Wainwright increased their Q2 2025 earnings estimates for shares of Gain Therapeutics in a note issued to investors on Monday, May 19th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings of ($0.16) per share for the quarter, up from […]
